# GNAT1

## Overview
The GNAT1 gene encodes the G protein subunit alpha transducin 1, a pivotal component of the phototransduction pathway in retinal rod cells. This protein is part of the heterotrimeric G-protein complex, which plays a crucial role in converting light signals into electrical signals, thereby facilitating vision in low-light conditions. The GNAT1-encoded protein is categorized as a G protein, which interacts with other proteins and molecules to propagate visual signals. Upon activation by photoactivated rhodopsin, the GNAT1 protein binds guanosine triphosphate (GTP), leading to a cascade of events that result in the hyperpolarization of the photoreceptor cell membrane and the generation of an electrical response to light (Kubota2019Novel; Calvert2000Phototransduction). Mutations in GNAT1 are associated with various visual disorders, including congenital stationary night blindness and retinal degeneration, underscoring its importance in maintaining normal visual function (Szabo2007p.Gln200Glu; Carrigan2015A).

## Structure
The GNAT1 gene encodes the alpha subunit of transducin, a G protein involved in the phototransduction pathway in retinal rod cells. The primary structure of GNAT1 consists of a sequence of amino acids forming the polypeptide chain, which is crucial for its function in signal transduction. The secondary structure includes regions of alpha helices and beta sheets, which contribute to the protein's stability and function. The tertiary structure of GNAT1 is its three-dimensional conformation, essential for its interaction with other proteins and molecules in the phototransduction pathway.

In terms of quaternary structure, GNAT1 interacts with beta and gamma subunits to form a heterotrimeric G protein complex. This interaction is vital for its role in signal transduction, as it allows the protein to effectively transmit signals from activated rhodopsin to downstream effectors. Common post-translational modifications of GNAT1 include myristoylation and phosphorylation, which are important for membrane attachment and functional regulation of the protein (Fonin2019Multifunctionality).

The GNAT1 protein also exhibits a moderate level of intrinsic disorder, with a protein disorder ratio of 23.7%, indicating flexibility in its structure that may facilitate interactions with other proteins and regulatory molecules (Fonin2019Multifunctionality).

## Function
The GNAT1 gene encodes the alpha subunit of rod transducin, a crucial component of the phototransduction cascade in retinal rod cells. This protein is part of a heterotrimeric G-protein complex that plays a vital role in converting light signals into electrical signals, a process essential for vision in low-light conditions (Szabo2007p.Gln200Glu; Kubota2019Novel). In healthy human cells, the GNAT1-encoded alpha subunit binds guanosine triphosphate (GTP) upon activation by photoactivated rhodopsin. This binding triggers the dissociation of the alpha subunit from the beta and gamma subunits, allowing it to activate cyclic guanosine monophosphate-phosphodiesterase (cGMP-PDE) (Szabo2007p.Gln200Glu; Carrigan2015A).

The activation of cGMP-PDE leads to the hydrolysis of cGMP, resulting in the closure of cGMP-gated ion channels and the hyperpolarization of the photoreceptor cell membrane. This change in membrane potential generates an electrical response to light, facilitating visual signal transduction (Kubota2019Novel; Méjécase2016Identification). The GNAT1 protein's function is critical for the proper operation of rod cells, which are responsible for vision under low-light conditions (Méjécase2016Identification).

## Clinical Significance
Mutations in the GNAT1 gene, which encodes the alpha subunit of rod transducin, are associated with several visual disorders. One notable condition is autosomal dominant congenital stationary night blindness (adCSNB), characterized by impaired night vision due to defects in rod photoreceptors. A specific mutation, p.Gln200Glu, leads to constitutive activation of rod α-transducin, causing persistent activation of the phototransduction cascade, which is a major molecular cause of adCSNB (Szabo2007p.Gln200Glu).

GNAT1 mutations are also linked to autosomal recessive congenital stationary night blindness (arCSNB) and rod-cone dystrophy (RCD), a progressive retinal disease. A novel homozygous nonsense mutation, c.963C>A p.(Cys321*), results in a truncated protein and is associated with severe rod-cone dystrophy, highlighting the variability in phenotypic severity (Méjécase2016Identification).

Additionally, a homozygous truncating mutation in GNAT1 has been implicated in retinal degeneration, specifically retinitis pigmentosa, characterized by pigmentary disturbance and visual field constriction (Carrigan2015A). These findings underscore the diverse clinical manifestations associated with GNAT1 mutations.

## Interactions
The GNAT1 protein, also known as G protein subunit alpha transducin 1, is a critical component of the phototransduction pathway in retinal cells. It interacts with several key proteins to facilitate visual signal transduction. GNAT1 forms part of a heterotrimeric G-protein complex that includes the transducin β and γ subunits. Upon activation by light-activated rhodopsin, GNAT1 undergoes a conformational change that allows it to bind GTP, dissociate from the βγ subunits, and interact with other proteins in the signaling cascade (Szabo2007p.Gln200Glu).

One of the primary interactions of GNAT1 is with rhodopsin, which catalyzes the exchange of GDP for GTP on the GNAT1 α-subunit, initiating the phototransduction cascade (Calvert2000Phototransduction). GNAT1 also interacts with phosphodiesterase 6 (PDE6), specifically binding to its γ-subunit. This interaction is crucial for the hydrolysis of cGMP, leading to the closure of cGMP-gated ion channels and the hyperpolarization of the photoreceptor cell membrane (Szabo2007p.Gln200Glu).

Mutations in GNAT1 can disrupt these interactions, leading to conditions such as congenital stationary night blindness and retinal degeneration, highlighting the importance of its interactions in maintaining normal visual function (Szabo2007p.Gln200Glu; Carrigan2015A).


## References


[1. (Kubota2019Novel) Daiki Kubota, Noriko Oishi, Kiyoko Gocho, Sachiko Kikuchi, Kunihiko Yamaki, Tsutomu Igarashi, Hiroshi Takahashi, Nobuo Ishida, Takeshi Iwata, Atsushi Mizota, and Shuhei Kameya. Novel homozygous in-frame deletion ofgnat1gene causes golden appearance of fundus and reduced scotopic ergs similar to that in oguchi disease in japanese family. Ophthalmic Genetics, 40(5):480–487, September 2019. URL: http://dx.doi.org/10.1080/13816810.2019.1686159, doi:10.1080/13816810.2019.1686159. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/13816810.2019.1686159)

[2. (Szabo2007p.Gln200Glu) Viktoria Szabo, Hans-Jürgen Kreienkamp, Thomas Rosenberg, and Andreas Gal. P.gln200glu, a putative constitutively active mutant of rod α-transducin (gnat1) in autosomal dominant congenital stationary night blindness. Human Mutation, 28(7):741–742, 2007. URL: http://dx.doi.org/10.1002/humu.9499, doi:10.1002/humu.9499. This article has 30 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.9499)

[3. (Carrigan2015A) Matthew Carrigan, Emma Duignan, Pete Humphries, Arpad Palfi, Paul F Kenna, and G Jane Farrar. A novel homozygous truncatinggnat1mutation implicated in retinal degeneration. British Journal of Ophthalmology, 100(4):495–500, October 2015. URL: http://dx.doi.org/10.1136/bjophthalmol-2015-306939, doi:10.1136/bjophthalmol-2015-306939. This article has 31 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1136/bjophthalmol-2015-306939)

[4. (Calvert2000Phototransduction) P. D. Calvert, N. V. Krasnoperova, A. L. Lyubarsky, T. Isayama, M. Nicoló, B. Kosaras, G. Wong, K. S. Gannon, R. F. Margolskee, R. L. Sidman, E. N. Pugh, C. L. Makino, and J. Lem. Phototransduction in transgenic mice after targeted deletion of the rod transducin α-subunit. Proceedings of the National Academy of Sciences, 97(25):13913–13918, November 2000. URL: http://dx.doi.org/10.1073/pnas.250478897, doi:10.1073/pnas.250478897. This article has 292 citations.](https://doi.org/10.1073/pnas.250478897)

[5. (Fonin2019Multifunctionality) Alexander V. Fonin, April L. Darling, Irina M. Kuznetsova, Konstantin K. Turoverov, and Vladimir N. Uversky. Multi-functionality of proteins involved in gpcr and g protein signaling: making sense of structure–function continuum with intrinsic disorder-based proteoforms. Cellular and Molecular Life Sciences, 76(22):4461–4492, August 2019. URL: http://dx.doi.org/10.1007/s00018-019-03276-1, doi:10.1007/s00018-019-03276-1. This article has 50 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-019-03276-1)

[6. (Méjécase2016Identification) Cécile Méjécase, Caroline Laurent-Coriat, Claudine Mayer, Olivier Poch, Saddek Mohand-Saïd, Camille Prévot, Aline Antonio, Fiona Boyard, Christel Condroyer, Christelle Michiels, Steven Blanchard, Mélanie Letexier, Jean-Paul Saraiva, José-Alain Sahel, Isabelle Audo, and Christina Zeitz. Identification of a novel homozygous nonsense mutation confirms the implication of gnat1 in rod-cone dystrophy. PLOS ONE, 11(12):e0168271, December 2016. URL: http://dx.doi.org/10.1371/journal.pone.0168271, doi:10.1371/journal.pone.0168271. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0168271)